Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 5
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Thyrotab 800 µg V/DCP/24/0004 CP-Pharma Handelsgesellschaft GmbH, Vācija QH03AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Levothyroxine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 12-Jan-2024
Marketing authorisation valid until: 11-Jan-2029
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (12-Jan-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0004-01 800 µg/tabl. 3 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0004-02 800 µg/tabl. 10 AL/PVC-AL-PA blisteris, 10 tablete -
Thyrotab 600 µg V/DCP/24/0003 CP-Pharma Handelsgesellschaft GmbH, Vācija QH03AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Levothyroxine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 12-Jan-2024
Marketing authorisation valid until: 11-Jan-2029
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (12-Jan-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0003-01 600 µg/tabl. 3 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0003-02 600 µg/tabl. 10 AL/PVC-AL-PA blisteris, 10 tablete -
Thyrotab 400 µg V/DCP/24/0002 CP-Pharma Handelsgesellschaft GmbH, Vācija QH03AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Levothyroxine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 12-Jan-2024
Marketing authorisation valid until: 11-Jan-2029
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (12-Jan-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0002-01 400 µg/tabl. 3 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0002-02 400 µg/tabl. 10 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0002-03 400 µg/tabl. 25 AL/PVC-AL-PA blisteris, 10 tablete -
Thyrotab 200 µg V/DCP/24/0001 CP-Pharma Handelsgesellschaft GmbH, Vācija QH03AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Levothyroxine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 12-Jan-2024
Marketing authorisation valid until: 11-Jan-2029
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (12-Jan-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0001-01 200 µg/tabl. 3 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0001-02 200 µg/tabl. 10 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0001-03 200 µg/tabl. 25 AL/PVC-AL-PA blisteris, 10 tablete -
Varroxal 0.71 g/g V/MRP/24/0010 Andermatt Biovet GmbH, Vācija QP53AG03 honey bees Vairāk

Medicinal product information

Pharmaceutical form: Powder for in-hive use
International name (active substance): Oxalic acid dihydrate
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Andermatt Biovet GmbH, Vācija
Date of authorisation/renewal: 17-Jan-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Jan-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (17-Jan-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/24/0010-01 0,71 g/g 10 Maisiņš, 2 g -
V/MRP/24/0010-02 0,71 g/g 50 Maisiņš, 2 g -
V/MRP/24/0010-03 0,71 g/g 1 ABPE pudelīte, 75 g -
V/MRP/24/0010-04 0,71 g/g 1 ABPE pudelīte, 200 g -
Tramsan 20 mg V/DCP/24/0015 Alfasan Nederland BV, Nīderlande QN02AX02 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Tramadol hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 12-Feb-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Feb-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Feb-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (12-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0015-01 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0015-02 2 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0015-03 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0015-04 4 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0015-05 5 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0015-06 6 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0015-07 7 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0015-08 8 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0015-09 9 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0015-10 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0015-11 12 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0015-12 25 PVH/PE/PVDH-Al blisteris, 10 tablete -
Tramsan 80 mg V/DCP/24/0016 Alfasan Nederland BV, Nīderlande QN02AX02 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Tramadol hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 12-Feb-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Feb-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Feb-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (12-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0016-01 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0016-02 2 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0016-03 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0016-04 4 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0016-05 5 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0016-06 6 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0016-07 7 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0016-08 8 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0016-09 9 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0016-10 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0016-11 12 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0016-12 25 PVH/PE/PVDH-Al blisteris, 10 tablete -
VETEGLAN 0.075 mg/ml V/SRP/23/0038 Laboratorios Calier, S.A., Spānija QG02AD90 sows; mares; cows Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): D-cloprostenol
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Laboratorios Calier, S.A., Spānija
Date of authorisation/renewal: 27-Jul-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: SRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jul-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jul-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Aug-2024)

Products

ID Strength Package size Primary packaging Labelling
V/SRP/23/0038-01 1 Stikla flakons, 10 ml -
V/SRP/23/0038-02 1 Stikla flakons, 20 ml -
Animedazon 2.45 % V/MRP/15/0020 aniMedica GmbH, Vācija QD06AA02 cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: cutaneous spray, suspension
International name (active substance): Chlortetracycline hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija
Date of authorisation/renewal: 27-May-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Feb-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Feb-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (07-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/15/0020-01 2,45 % 1 Pudele, 211 ml -
V/MRP/15/0020-02 2,45 % 12 Pudele, 211 ml -
Nobilis RT+IBmulti+G+ND - V/NRP/03/1535 Intervet International B.V., Nīderlande QI01AA06 chickens Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Infectious Bronchitis virus strain,Inactivated infectious bronchitis virus, serotype Massachusetts, strain M41,Inactivated Newcastle disease virus, strain Clone 30,Inactivated infectious bursal disease virus, strain D78
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International Booxmer, Nīderlande
Date of authorisation/renewal: 15-Jul-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Oct-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Oct-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Oct-2023)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/03/1535-01 1 Flakons, 500 ml -
V/NRP/03/1535-02 1 Flakons, 250 ml -
Thyrovet 200 µg V/DCP/24/0005 CP-Pharma Handelsgesellschaft GmbH, Vācija QH03AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Levothyroxine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 12-Jan-2024
Marketing authorisation valid until: 11-Jan-2029
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (28-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0005-01 200 µg/tabl. 3 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0005-02 200 µg/tabl. 10 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0005-03 200 µg/tabl. 25 AL/PVC-AL-PA blisteris, 10 tablete -
Thyrovet 400 µg V/DCP/24/0006 CP-Pharma Handelsgesellschaft GmbH, Vācija QH03AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Levothyroxine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 12-Jan-2024
Marketing authorisation valid until: 11-Jan-2029
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (28-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0006-01 400 µg/tabl. 3 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0006-02 400 µg/tabl. 10 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0006-03 400 µg/tabl. 25 AL/PVC-AL-PA blisteris, 10 tablete -
Thyrovet 600 µg V/DCP/24/0007 CP-Pharma Handelsgesellschaft GmbH, Vācija QH03AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Levothyroxine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 12-Jan-2024
Marketing authorisation valid until: 11-Jan-2029
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Jan-2024)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (28-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0007-01 600 µg/tabl. 3 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0007-02 600 µg/tabl. 10 AL/PVC-AL-PA blisteris, 10 tablete -
Ubrolexin - V/MRP/08/1587 Boehringer Ingelheim Vetmedica GmbH, Vācija QJ51RD01 cattle Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Cefalexin,Kanamycin sulphate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Univet Ltd., Īrija
Date of authorisation/renewal: 07-Dec-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/08/1587-01 10 Injektors, 1 deva -
V/MRP/08/1587-02 20 Injektors, 1 deva -
EFICUR 50 mg/ml V/MRP/08/1604 Laboratorios Hipra S.A., Spānija QJ01DD90 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Ceftiofur (as ceftiofur hydrochloride)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Laboratorios Hipra S.A., Spānija
Date of authorisation/renewal: 02-Mar-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (01-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (01-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (01-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/08/1604-01 50 mg/ml 1 Stikla pudelīte, 100 ml -
V/MRP/08/1604-02 50 mg/ml 1 Stikla pudelīte, 250 ml -
V/MRP/08/1604-03 50 mg/ml 10 Stikla flakons, 100 ml -
V/MRP/08/1604-05 50 mg/ml 1 Stikla pudelīte, 50 ml -
V/MRP/08/1604-06 50 mg/ml 12 Stikla pudele, 100 ml -
V/MRP/08/1604-07 50 mg/ml 1 Polietilēna pudele, 50 ml -
V/MRP/08/1604-08 50 mg/ml 1 Polietilēna pudele, 100 ml -
V/MRP/08/1604-09 50 mg/ml 1 Polietilēna pudele, 250 ml -
Fypryst Combo 402mg/361,8mg - V/DCP/14/0013 KRKA, d.d., Novo mesto, Slovēnija QP53AX65 very large dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil,S-Methoprene
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 27-Feb-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (22-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0013-01 1 Polipropilēna pipete, 1 deva -
V/DCP/14/0013-02 3 Polipropilēna pipete, 1 deva -
V/DCP/14/0013-03 6 Polipropilēna pipete, 1 deva -
V/DCP/14/0013-04 10 Polipropilēna pipete, 1 deva [PDF]
Pereprin 5 mg/ml V/DCP/25/0077 Huvepharma NV, Beļģija QP54AA04 cattle; sheep; goats Vairāk

Medicinal product information

Pharmaceutical form: pour-on solution
International name (active substance): Eprinomectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Biovet AD, Bulgārija
Date of authorisation/renewal: 12-Dec-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (12-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (12-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0077-01 1 ABPE pudele, 250 ml -
V/DCP/25/0077-02 1 ABPE pudele, 1 l -
V/DCP/25/0077-03 1 ABPE pudele, 2,5 l -
V/DCP/25/0077-04 1 ABPE pudele, 5 l -
TOP SPOT ON STRONGER sol. ad us. vet. 650 mg/ml V/NRP/03/1590 Bioveta, a.s., Čehija QP53AC04 horses; dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Permethrin
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 22-Oct-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOC] 43-270209LI (09-Mar-2009)
Labelling text: [DOC] 09032009M (09-Mar-2009)
Summary of product characteristics: [DOC] 43-270209ZA (09-Mar-2009)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/03/1590-01 650 mg/ml 1 Kontūriepakojums, 1 ml -
V/NRP/03/1590-02 650 mg/ml 2 Kontūriepakojums, 1 ml -
V/NRP/03/1590-03 650 mg/ml 3 Kontūriepakojums, 1 ml -
V/NRP/03/1590-04 650 mg/ml 25 Kontūriepakojums, 1 ml -
V/NRP/03/1590-05 650 mg/ml 50 Kontūriepakojums, 1 ml -
V/NRP/03/1590-06 650 mg/ml 100 Kontūriepakojums, 1 ml -
V/NRP/03/1590-07 650 mg/ml 1 Kontūriepakojums, 25 ml -
V/NRP/03/1590-08 650 mg/ml 6 Kontūriepakojums, 25 ml -
Cartaxx 20 mg V/DCP/25/0073 Alfasan Nederland BV, Nīderlande QM01AE91 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Carprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 10-Dec-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (10-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0073-01 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0073-02 2 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0073-03 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0073-04 4 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0073-05 5 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0073-06 6 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0073-07 7 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0073-08 8 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0073-09 9 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0073-10 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0073-11 12 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0073-12 25 PVH/PE/PVDH-Al blisteris, 10 tablete -
Cartaxx 50 mg V/DCP/25/0074 Alfasan Nederland BV, Nīderlande QM01AE91 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Carprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 10-Dec-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (10-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0074-01 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0074-02 2 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0074-03 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0074-04 4 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0074-05 5 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0074-06 6 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0074-07 7 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0074-08 8 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0074-09 9 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0074-10 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0074-11 12 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0074-12 25 PVH/PE/PVDH-Al blisteris, 10 tablete -

3082 records

© Food and veterinary service · 2026 Cookies policy